Q3 2025 Rockwell Medical Inc Earnings Call Transcript
Key Points
- Rockwell Medical Inc (RMTI) reported profitability on an adjusted EBITDA basis for the third quarter, indicating progress towards sustainable profitability.
- Over 80% of Rockwell Medical Inc (RMTI)'s customers are operating under long-term agreements, providing stability and revenue visibility.
- The company has successfully diversified its customer base, reducing dependence on any single customer.
- Rockwell Medical Inc (RMTI) signed several new long-term product purchasing agreements, including a significant contract with a dialysis center in Southern Florida.
- The introduction of the bicarbonate cartridge has opened up higher margin product opportunities, with existing customers beginning to adopt this new product.
- Net sales for the third quarter were $15.9 million, representing a 44% decrease compared to the same period in 2024, primarily due to the transition of the largest customer to another supplier.
- Gross profit for the third quarter was $2.3 million, a 64% decrease compared to the same period in 2024.
- Net loss for the third quarter of 2025 was $1.8 million, compared to a net income of $1.7 million for the same period in 2024.
- The gross margin for the third quarter was 14%, down from 22% in the same period in 2024.
- The company is still in discussions with its formerly largest customer, which continues to rely on Rockwell Medical Inc (RMTI) due to operational challenges with their new supplier.
Good morning and welcome to Rockwell Medical's third quarter 2025 results conference call and webcast.
(Operator Instructions)
At this time, I would like to turn the conference call over to Heather Hunter, Chief Operating Officer at Rockwell Medical. Heather, please go ahead.
Good morning and thank you for joining us for this update on Rockwell Medical. Joining me on today's conference call are Dr. Mark Strobeck, Rockwell Medical's President and Chief Executive Officer, and Jessie Ney, Rockwell Medical's Chief Financial Officer.
Before we begin, I would like to remind you that this conference call will contain forward-looking statements about Rockwell Medical within the meeting of the federal securities laws, including but not limited to the types of statements identified as forward-looking in our annual report on Form 10K and our subsequent periodic reports filed with the SEC. These statements are subject to risks and uncertainties that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
